Pages that link to "Q48636372"

The following pages link to Milestones in umbilical cord blood transplantation (Q48636372):

Displaying 47 items.

• Cord blood graft engineering (Q26822376) (← links)
• A comparative analysis of the opinions from European national and international ethics committees regarding the collection, storage and use of umbilical cord blood (Q27002326) (← links)
• Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models (Q28727639) (← links)
• Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy (Q30557220) (← links)
• Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (Q33430004) (← links)
• A new strategy for umbilical cord blood collection developed at the first Colombian public cord blood bank increases total nucleated cell content (Q33486333) (← links)
• Spheroid Coculture of Hematopoietic Stem/Progenitor Cells and Monolayer Expanded Mesenchymal Stem/Stromal Cells in Polydimethylsiloxane Microwells Modestly Improves In Vitro Hematopoietic Stem/Progenitor Cell Expansion. (Q33580598) (← links)
• Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy (Q33800639) (← links)
• Umbilical cord blood transplantation: the first 25 years and beyond (Q34344669) (← links)
• Concise review: umbilical cord blood transplantation: past, present, and future (Q34601968) (← links)
• Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. (Q35034803) (← links)
• Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. (Q35199893) (← links)
• Novel chemical attempts at ex vivo hematopoietic stem cell expansion (Q35933970) (← links)
• Ethical and legal considerations regarding the ownership and commercial use of human biological materials and their derivatives (Q36229460) (← links)
• The Role of HLA in Cord Blood Transplantation. (Q36336608) (← links)
• The hematopoietic system in the context of regenerative medicine (Q36627127) (← links)
• Umbilical cord blood transplantation supported by third-party donor cells: rationale, results, and applications (Q36746512) (← links)
• Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. (Q37216236) (← links)
• Human Umbilical Cord Blood for Transplantation Therapy in Myocardial Infarction (Q37353891) (← links)
• The plasma levels of soluble HLA-G molecules correlate directly with CD34 cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors (Q37602425) (← links)
• Umbilical Cord Blood: Lessons Learned and Lingering Challenges After More Than 20 Years of Basic and Clinical Research (Q37966438) (← links)
• Hematopoietic Stem Cell Mobilization and Homing after Transplantation: The Role of MMP-2, MMP-9, and MT1-MMP. (Q38002032) (← links)
• Ethical issues in umbilical cord blood banking: a comparative analysis of documents from national and international institutions (Q38030627) (← links)
• Haematopoietic stem cell transplantation for SCID patients: where do we stand? (Q38061148) (← links)
• New strategies in cord blood cells transplantation (Q38099291) (← links)
• Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes (Q38520096) (← links)
• "Good mothering" or "good citizenship"? (Q39514528) (← links)
• Impact of cord blood banking technologies on clinical outcome: a Eurocord/Cord Blood Committee (CTIWP), European Society for Blood and Marrow Transplantation and NetCord retrospective analysis. (Q39721991) (← links)
• A novel method to expand large numbers of CD56( ) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation. (Q41268656) (← links)
• Combined cord blood and bone marrow transplantation from the same human leucocyte antigen-identical sibling donor for children with malignant and non-malignant diseases (Q44664430) (← links)
• Long-term outcome and prognostic factors of unrelated cord blood transplantation in children with haematological malignancies: a retrospective study using the Spanish Working Party for BMT in Children (GETMON) database (Q44756831) (← links)
• Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment (Q44953364) (← links)
• Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of E (Q46788345) (← links)
• The first decade of advanced cell therapy clinical trials using perinatal cells (2005-2015). (Q50009004) (← links)
• A novel method of CD34 cell separation from umbilical cord blood. (Q50494724) (← links)
• Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies (Q51737112) (← links)
• Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34( ) cells. (Q53256317) (← links)
• Use of human embryonic stem cells and umbilical cord blood stem cells for research and therapy: a prospective survey among health care professionals and patients in Switzerland. (Q53750986) (← links)
• Knowledge, beliefs, and decisions of pregnant Australian women concerning donation and storage of umbilical cord blood: a population-based survey. (Q54742245) (← links)
• A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells. (Q55057708) (← links)
• Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency. (Q55334301) (← links)
• A prenatal prediction model for total nucleated cell count increases the efficacy of umbilical cord blood banking (Q56769430) (← links)
• Factors which can influence the quality related to cell viability of the umbilical cord blood units (Q85307404) (← links)
• Concepts, Utility and Limitations of Cord Blood Banking: What Clinicians Need to Know (Q88105650) (← links)
• The number of CD34 CD133 hematopoietic stem cells residing in umbilical cord blood (UCB) units is not correlated with the numbers of total nucleated cells and CD34 cells: a possible new indicator for quality evaluation of UCB units (Q90482108) (← links)
• Non-Inherited Maternal Antigens Identify Acceptable HLA Mismatches: A New Policy for the Hellenic Cord Blood Bank (Q91693923) (← links)
• GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans' Hematopoietic Stem Cells (Q99403536) (← links)